SEC Form 4 · accession 0001209191-15-028519

REVVITY, INC. · RVTY

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Please See Remarks

Period of report

Mar 20, 2015

Accepted (ET)

Mar 23, 2015 · 4:05 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000031791

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 20, 2015	M	2,087	$26.145	A	28,502	D
Common Stock	Mar 20, 2015	M	1,319	$33.87	A	29,821	D
Common Stock^F2	Mar 20, 2015	S	5,157	$50.228	D	24,664	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
NQ Stock Option (right to buy)^F3	$26.145	Mar 20, 2015	M	2,087	D	—	Feb 7, 2019	Common Stock	2,087	4,175	D
NQ Stock Option (right to buy)^F4	$33.87	Mar 20, 2015	M	1,319	D	—	Feb 5, 2020	Common Stock	1,319	9,232	D

F1The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Corbett on February 18, 2015.
F2The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $49.970 to $50.270. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F3This option became exercisable in three equal annual installments beginning on February 7, 2013, which was the first anniversary of the date on which the option was granted.
F4This option became exercisable in three equal annual installments beginning on February 5, 2014, which was the first anniversary of the date on which the option was granted.

Senior Vice President and President, Human Health